Malignant syphilis in HIV negative patient treated with ibrutinib

Rev Esp Quimioter. 2023 Dec;36(6):632-634. doi: 10.37201/req/027.2023. Epub 2023 Sep 29.

Authors

M Aroza-Espinar, A Merlán-Hermida, L Suárez-Hormiga, J L Pérez-Arellano¹

Affiliation

¹ José-Luis Pérez-Arellano, Unidad de Enfermedades Infecciosas y Medicina Tropical, Complejo Hospitalario InsularMaterno Infantil de Gran Canaria, Las Palmas de Gran Canaria, Spain. jlperez@dcmq.ulpgc.es.

No abstract available

Keywords: Ibrutinib; malignant syphilis; non-HIV; sexually transmitted infection.

Publication types

Letter

MeSH terms

Adenine / therapeutic use
HIV Infections* / complications
HIV Infections* / drug therapy
Humans
Piperidines / therapeutic use
Syphilis* / complications
Syphilis* / drug therapy

Substances

ibrutinib
Piperidines
Adenine